Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis

Youngkyun Lee1, Jeongim Ha, Hyung Joon Kim

  • 1Department of Cell and Developmental Biology, BK21 Program and DRI, Seoul National University, 28 Yeongon-Dong, Chongno-Gu, Seoul 110-749, Korea.

Insights

DYRK1A kinase, linked to Down syndrome, plays a novel role in bone health. Overexpression impairs bone mass by affecting osteoblasts, but protects against bone loss in certain conditions.

Area of Science:

  • Molecular Biology
  • Bone Biology
  • Genetics

Background:

  • DYRK1A (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A) is known for its role in cognitive development, particularly in Down syndrome.
  • Its function in bone homeostasis has not been previously elucidated.

Purpose of the Study:

  • To investigate the role of DYRK1A in bone homeostasis and its potential involvement in bone-related diseases.
  • To explore the molecular mechanisms by which DYRK1A influences osteoclast and osteoblast function.

Main Methods:

  • In vitro studies using osteoclasts to assess DYRK1A's effect on osteoclastogenesis.
  • Analysis of DYRK1A phosphorylation of NFATc1 and the feedback loop.
  • Generation and analysis of transgenic mice overexpressing DYRK1A.

Main Results:

  • DYRK1A expression increased during osteoclast differentiation and inhibited osteoclastogenesis by phosphorylating NFATc1.
  • Overexpression of DYRK1A in mice led to reduced bone mass, mimicking Down syndrome phenotypes, due to impaired osteoblast function.
  • Inhibited osteoclastogenesis in DYRK1A transgenic mice offered protection against inflammation- or estrogen deficiency-induced bone loss.

Conclusions:

  • DYRK1A plays a significant role in regulating bone homeostasis, impacting both osteoclast and osteoblast lineages.
  • DYRK1A's dual role suggests potential therapeutic strategies for bone destructive diseases by modulating its activity.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...